1. Home
  2. AMRX vs NAVN Comparison

AMRX vs NAVN Comparison

Compare AMRX & NAVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$14.82

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

NAVN

Navan Inc.

N/A

Current Price

$10.44

Market Cap

3.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
AMRX
NAVN
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
AMRX
NAVN
Price
$14.82
$10.44
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$13.25
$24.80
AVG Volume (30 Days)
3.8M
1.7M
Earning Date
02-27-2026
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$2,934,959,000.00
$656,339,000.00
Revenue This Year
$9.99
$30.17
Revenue Next Year
$6.48
$22.56
P/E Ratio
$789.64
N/A
Revenue Growth
9.50
63.16
52 Week Low
$6.69
$9.87
52 Week High
$15.00
$22.75

Technical Indicators

Market Signals
Indicator
AMRX
NAVN
Relative Strength Index (RSI) 67.23 34.18
Support Level $14.55 $10.18
Resistance Level $14.99 $11.67
Average True Range (ATR) 0.48 0.87
MACD 0.01 -0.11
Stochastic Oscillator 78.84 10.80

Price Performance

Historical Comparison
AMRX
NAVN

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About NAVN Navan Inc.

Navan Inc is an end-to-end, AI-powered software platform built to simplify the world-wide business T&E experience, benefiting users, customers, and suppliers. Its leveraged technology to reimagine business travel. The company deliver delightful, personalized experiences for users, efficiency and control for customers, and direct market access for suppliers-all powered by its proprietary AI framework, Navan Cognition. Geographically, the company operates in United States, United Kingdom and Other countries, of which United States derives maximum revenue.

Share on Social Networks: